Hirotaka Tanaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hirotaka Tanaka has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
Masayoshi Tei
Department of Otorhinolaryngology, The JIKEI University School of Medicine, Japan
5 shared publications- Eri Mori
Department of Otorhinolaryngology The Jikei University School of Medicine Tokyo Japan
4 shared publications Nobuyoshi Otori
Department of Otorhinolaryngology Head and Neck Surgery The Jikei University School of Medicine Tokyo Japan
4 shared publicationsNagomi Yonezawa
Department of Otorhinolaryngology, Jikei University School of Medicine
3 shared publicationsRumi Sekine
Department of Otorhinolaryngology Head and Neck Surgery The Jikei University School of Medicine Tokyo Japan
3 shared publicationsEri Mori
Department of Otorhinolaryngology, The JIKEI University School of Medicine, Japan
2 shared publications
Latest Publications
- Open Access
- 3 May 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (3)
Changes in the Epidemiology of Pediatric Olfactory Dysfunction Before and After COVID ‐19 Pandemic
Background: The COVID‐19 pandemic may have altered the epidemiology and clinical features of pediatric olfactory dysfunction, but data focusing on children remain limited, particularly regarding etiological changes and qualitative symptoms such as parosmia. This study investigated temporal changes in pediatric presentations at a tertiary smell clinic. Methodology/Principal: We retrospectively reviewed patients younger than 18 years who visited our clinic for olfactory dysfunction between January 2009 and December 2024. Patients were divided into pre‐pandemic (January 2009–March 2020) and post‐pandemic (April 2020–December 2024) cohorts. Etiology was determined using clinical history, imaging, nasal endoscopy, and psychophysical and subjective olfactory tests. Results: The proportion of pediatric patients among all patients with olfactory dysfunction increased significantly from 1.5% (35/2322) in the pre‐pandemic cohort to 4.7% (48/1022) in the post‐pandemic cohort ( p < 0.01), with a corresponding decrease in adults. Etiological distribution shifted significantly ( p < 0.01): olfactory cleft stenosis predominated in pre‐pandemic, whereas upper respiratory tract infection became the leading cause in the post‐pandemic cohort, 76% of cases of which related to COVID‐19. Parosmia was observed exclusively in post‐COVID‐19 pediatric patients. Subjective olfactory scores were higher with post‐pandemic patients, indicating more mildly perceived dysfunction, while psychophysical test results showed no significant differences. Conclusions: After the COVID‐19 pandemic, pediatric olfactory dysfunction became more frequent and was predominantly associated with post‐infectious causes, particularly COVID‐19, with parosmia emerging as a characteristic feature. Greater clinical awareness and pediatric‐specific diagnostic standards will be needed. Level of Evidence: Level 3.
- 3 May 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (3)
Open AccessChanges in the Epidemiology of Pediatric Olfactory Dysfunction Before and After COVID ‐19 Pandemic
Background: The COVID‐19 pandemic may have altered the epidemiology and clinical features of pediatric olfactory dysfunction, but data focusing on children remain limited, particularly regarding etiological changes and qualitative symptoms such as parosmia. This study investigated temporal changes in pediatric presentations at a tertiary smell clinic. Methodology/Principal: We retrospectively reviewed patients younger than 18 years who visited our clinic for olfactory dysfunction between January 2009 and December 2024. Patients were divided into pre‐pandemic (January 2009–March 2020) and post‐pandemic (April 2020–December 2024) cohorts. Etiology was determined using clinical history, imaging, nasal endoscopy, and psychophysical and subjective olfactory tests. Results: The proportion of pediatric patients among all patients with olfactory dysfunction increased significantly from 1.5% (35/2322) in the pre‐pandemic cohort to 4.7% (48/1022) in the post‐pandemic cohort ( p < 0.01), with a corresponding decrease in adults. Etiological distribution shifted significantly ( p < 0.01): olfactory cleft stenosis predominated in pre‐pandemic, whereas upper respiratory tract infection became the leading cause in the post‐pandemic cohort, 76% of cases of which related to COVID‐19. Parosmia was observed exclusively in post‐COVID‐19 pediatric patients. Subjective olfactory scores were higher with post‐pandemic patients, indicating more mildly perceived dysfunction, while psychophysical test results showed no significant differences. Conclusions: After the COVID‐19 pandemic, pediatric olfactory dysfunction became more frequent and was predominantly associated with post‐infectious causes, particularly COVID‐19, with parosmia emerging as a characteristic feature. Greater clinical awareness and pediatric‐specific diagnostic standards will be needed. Level of Evidence: Level 3.
- Open Access
- 12 January 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (1) , 111-127
Summary of Japanese clinical practice guidelines 2025 for the management of olfactory dysfunction
- 12 January 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (1) , 111-127
Open AccessSummary of Japanese clinical practice guidelines 2025 for the management of olfactory dysfunction
- Open Access
Olfactory cleft obstruction in post-COVID-19 olfactory disorder: CT Comparison with post-viral cases
SUMMARY: Background: Post-COVID-19 olfactory dysfunction (PCOD) is a common sequela of SARS-CoV-2 infection, with some cases persisting beyond the acute phase. While prolonged PCOD has been considered primarily sensorineural, recent studies suggest that olfactory cleft (OC) obstruction may contribute to olfactory dysfunction (OD). This study aimed to investigate OC obstruction in prolonged PCOD compared to post-infectious olfactory dysfunction (PIOD) and assess its impact on olfactory function. Methodology/Principal: We retrospectively analysed sinus computed tomography scans of patients with prolonged PCOD and PIOD. OC obstruction was classified into absent (0%), mild (1–90%), and severe (>90%) types. The severity of OC obstruction was compared between PCOD and PIOD cases, and olfactory test results were analysed according to OC obstruction severity. Results: A total of 87 PCOD patients and 67 PIOD patients were included. Mild and severe OC obstruction was more prevalent and severe in prolonged PCOD (mild: 35.6%, severe: 18.4%) than PIOD (mild: 13.4%, severe: 3%). Moreover, worsened olfactory function was found in PCOD patients with severe OC obstruction. In contrast, OC obstruction showed little association with olfactory function in PIOD patients. Conclusions: Mild and Severe OC obstruction appear to be more common in prolonged PCOD. Moreover, severe OC obstruction may further impair olfactory function in PCOD patients. Conversely, severe OD in PIOD patients occurred independently of OC obstruction .
Open AccessOlfactory cleft obstruction in post-COVID-19 olfactory disorder: CT Comparison with post-viral cases
SUMMARY: Background: Post-COVID-19 olfactory dysfunction (PCOD) is a common sequela of SARS-CoV-2 infection, with some cases persisting beyond the acute phase. While prolonged PCOD has been considered primarily sensorineural, recent studies suggest that olfactory cleft (OC) obstruction may contribute to olfactory dysfunction (OD). This study aimed to investigate OC obstruction in prolonged PCOD compared to post-infectious olfactory dysfunction (PIOD) and assess its impact on olfactory function. Methodology/Principal: We retrospectively analysed sinus computed tomography scans of patients with prolonged PCOD and PIOD. OC obstruction was classified into absent (0%), mild (1–90%), and severe (>90%) types. The severity of OC obstruction was compared between PCOD and PIOD cases, and olfactory test results were analysed according to OC obstruction severity. Results: A total of 87 PCOD patients and 67 PIOD patients were included. Mild and severe OC obstruction was more prevalent and severe in prolonged PCOD (mild: 35.6%, severe: 18.4%) than PIOD (mild: 13.4%, severe: 3%). Moreover, worsened olfactory function was found in PCOD patients with severe OC obstruction. In contrast, OC obstruction showed little association with olfactory function in PIOD patients. Conclusions: Mild and Severe OC obstruction appear to be more common in prolonged PCOD. Moreover, severe OC obstruction may further impair olfactory function in PCOD patients. Conversely, severe OD in PIOD patients occurred independently of OC obstruction .
- Open Access
- 2 April 2024
- Published by S. Karger AG in ORL
- Vol. 86 (2) , 73-81
Efficacy of Normalising Serum Zinc Level for Patients with Olfactory Dysfunction and Zinc Deficiency
Introduction: Zinc deficiency may worsen the severity of olfactory dysfunction; however, the relationship between serum zinc levels and therapeutic effects on olfactory dysfunction remains uncertain. This study investigated the relationship between normalising serum zinc levels and the therapeutic effects on olfactory dysfunction. Methods: Forty-two patients diagnosed with post-infectious, post-traumatic, and idiopathic olfactory dysfunction, with serum zinc levels <70 μg/dL, were included in the study. All patients were treated with mecobalamin, tokishakuyakusan, and polaprezinc. The patients were divided into 2 groups: the zinc-normalised (≥70 μg/dL) and zinc-deficient (<70 μg/dL) groups, based on their post-treatment serum zinc levels. Olfactory test results were compared in each of the 2 groups. Results: The patients were treated for a median of 133 days. The zinc-normalised group had significantly better results in all olfactory tests (detection/recognition thresholds of the T&T olfactometer, odour identification test (Open Essence), Visual Analogue Scale for olfactory dysfunction, and self-administered odour questionnaire). In contrast, only the self-administered odour questionnaire showed a significant improvement in the zinc-deficient group, with no significant differences observed in the other olfactory tests. When comparing the changes in the olfactory test scores between the 2 groups, significant differences were observed in the detection/recognition thresholds of the T&T olfactometer test and Open Essence results. Conclusion: These findings suggest that patients with olfactory dysfunction may have difficulty improving their olfactory function if they also have zinc deficiency. Furthermore, normalisation of zinc deficiency may contribute to the improvement of olfactory dysfunction with general treatment.
- 2 April 2024
- Published by S. Karger AG in ORL
- Vol. 86 (2) , 73-81
Open AccessEfficacy of Normalising Serum Zinc Level for Patients with Olfactory Dysfunction and Zinc Deficiency
Introduction: Zinc deficiency may worsen the severity of olfactory dysfunction; however, the relationship between serum zinc levels and therapeutic effects on olfactory dysfunction remains uncertain. This study investigated the relationship between normalising serum zinc levels and the therapeutic effects on olfactory dysfunction. Methods: Forty-two patients diagnosed with post-infectious, post-traumatic, and idiopathic olfactory dysfunction, with serum zinc levels <70 μg/dL, were included in the study. All patients were treated with mecobalamin, tokishakuyakusan, and polaprezinc. The patients were divided into 2 groups: the zinc-normalised (≥70 μg/dL) and zinc-deficient (<70 μg/dL) groups, based on their post-treatment serum zinc levels. Olfactory test results were compared in each of the 2 groups. Results: The patients were treated for a median of 133 days. The zinc-normalised group had significantly better results in all olfactory tests (detection/recognition thresholds of the T&T olfactometer, odour identification test (Open Essence), Visual Analogue Scale for olfactory dysfunction, and self-administered odour questionnaire). In contrast, only the self-administered odour questionnaire showed a significant improvement in the zinc-deficient group, with no significant differences observed in the other olfactory tests. When comparing the changes in the olfactory test scores between the 2 groups, significant differences were observed in the detection/recognition thresholds of the T&T olfactometer test and Open Essence results. Conclusion: These findings suggest that patients with olfactory dysfunction may have difficulty improving their olfactory function if they also have zinc deficiency. Furthermore, normalisation of zinc deficiency may contribute to the improvement of olfactory dysfunction with general treatment.
- 10 February 2023
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 280 (7) , 3229-3236
Relationship between the severity of olfactory dysfunction and serum zinc levels
Purpose Although the association between zinc deficiency and olfactory dysfunction is inconclusive, zinc deficiency causes apoptosis of the olfactory ensheathing cells which is involved in olfactory nerve turnover and axon regeneration, thereby suggesting a possible relationship. We investigated the relationship between serum zinc levels and olfactory function in patients with olfactory dysfunction. Methods Ninety patients who had been diagnosed with post-infectious, posttraumatic, drug-induced, neurological and idiopathic olfactory dysfunction were included. Patients were divided into zinc normal group and zinc deficiency groups according to three reference values for serum zinc levels (60, 65, 70 µg/dL). The results of olfactory tests and patient backgrounds were used to compare the differences between the two groups. Results There were significantly worse detection and recognition thresholds in the T&T olfactometer and Open Essence (odor identification test) results in the zinc deficiency group (< 60 µg/dL). In addition, significant correlations between olfactory tests (detection/recognition thresholds in the T&T olfactometer and Open Essence results) and serum zinc levels < 65 µg/dL were observed. The zinc deficiency group < 70 µg/dL with idiopathic olfactory dysfunction had significantly worse olfactory tests (detection/recognition thresholds in the T&T olfactometer and Open Essence). In addition, there was a significant correlation between the detection/recognition thresholds in the T&T olfactometer and serum zinc levels in idiopathic olfactory dysfunction. Conclusions Our findings suggest that zinc deficiency may exacerbate the severity of olfactory dysfunction. Furthermore, idiopathic olfactory dysfunction may be partly caused by zinc deficiency.
- 10 February 2023
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 280 (7) , 3229-3236
Relationship between the severity of olfactory dysfunction and serum zinc levels
Purpose Although the association between zinc deficiency and olfactory dysfunction is inconclusive, zinc deficiency causes apoptosis of the olfactory ensheathing cells which is involved in olfactory nerve turnover and axon regeneration, thereby suggesting a possible relationship. We investigated the relationship between serum zinc levels and olfactory function in patients with olfactory dysfunction. Methods Ninety patients who had been diagnosed with post-infectious, posttraumatic, drug-induced, neurological and idiopathic olfactory dysfunction were included. Patients were divided into zinc normal group and zinc deficiency groups according to three reference values for serum zinc levels (60, 65, 70 µg/dL). The results of olfactory tests and patient backgrounds were used to compare the differences between the two groups. Results There were significantly worse detection and recognition thresholds in the T&T olfactometer and Open Essence (odor identification test) results in the zinc deficiency group (< 60 µg/dL). In addition, significant correlations between olfactory tests (detection/recognition thresholds in the T&T olfactometer and Open Essence results) and serum zinc levels < 65 µg/dL were observed. The zinc deficiency group < 70 µg/dL with idiopathic olfactory dysfunction had significantly worse olfactory tests (detection/recognition thresholds in the T&T olfactometer and Open Essence). In addition, there was a significant correlation between the detection/recognition thresholds in the T&T olfactometer and serum zinc levels in idiopathic olfactory dysfunction. Conclusions Our findings suggest that zinc deficiency may exacerbate the severity of olfactory dysfunction. Furthermore, idiopathic olfactory dysfunction may be partly caused by zinc deficiency.
- Open Access
- 1 January 2023
- Published by SAGE Publications in Clinical Medicine Insights: Oncology
- Vol. 17
Characteristics of Extranodal NK/T-Cell Lymphoma, Nasal Type, Compared with Nasal Diffuse Large B-cell Lymphoma
Background: Extranodal NK/T-cell lymphoma, nasal type (ENKL), is an aggressive tumour with poor prognosis. Its early diagnosis may improve the prognosis of patients; however, it is often overlooked in many cases and misdiagnosed as an inflammatory sinus disease during its initial stage. Identifying the clinical characteristics of ENKL may aid otorhinolaryngologists in indicating cases early for a pathologic examination. In this study, we aimed to investigate the clinical characteristics of ENKL compared with that of diffuse large B-cell lymphoma (DLBCL), which is the most common nasal malignant lymphoma. Methods: The backgrounds, clinical symptoms, blood test results, and computed tomography images of patients with nasal/paranasal malignant lymphoma in our hospital between 2012 and 2017 were investigated. The characteristics of ENKL and nasal DLBCL were compared to differentiate them. Results: A total of 27 patients with nasal cavity and/or paranasal sinus lymphoma were included. Extranodal NK/T-cell lymphoma, nasal type, was diagnosed in 10 patients, while DLBCL was diagnosed in 17 patients. The median age of patients with ENKL was significantly lower than that of patients with DLBCL. All patients with ENKL had a unilateral lesion in the nasal cavity, with most located at the inferior turbinate. They also experienced nasal symptoms with significantly higher incidence of nasal obstruction and tendency of bleeding. Conclusion: ENKL was often unilateral and caused nasal obstruction, unlike DLBCL. Those who are younger in age and have sinonasal tumour with unilateral nasal obstruction and bleeding should be considered for early and repeated biopsies at multiple sites, with ENKL taken into consideration.
- 1 January 2023
- Published by SAGE Publications in Clinical Medicine Insights: Oncology
- Vol. 17
Open AccessCharacteristics of Extranodal NK/T-Cell Lymphoma, Nasal Type, Compared with Nasal Diffuse Large B-cell Lymphoma
Background: Extranodal NK/T-cell lymphoma, nasal type (ENKL), is an aggressive tumour with poor prognosis. Its early diagnosis may improve the prognosis of patients; however, it is often overlooked in many cases and misdiagnosed as an inflammatory sinus disease during its initial stage. Identifying the clinical characteristics of ENKL may aid otorhinolaryngologists in indicating cases early for a pathologic examination. In this study, we aimed to investigate the clinical characteristics of ENKL compared with that of diffuse large B-cell lymphoma (DLBCL), which is the most common nasal malignant lymphoma. Methods: The backgrounds, clinical symptoms, blood test results, and computed tomography images of patients with nasal/paranasal malignant lymphoma in our hospital between 2012 and 2017 were investigated. The characteristics of ENKL and nasal DLBCL were compared to differentiate them. Results: A total of 27 patients with nasal cavity and/or paranasal sinus lymphoma were included. Extranodal NK/T-cell lymphoma, nasal type, was diagnosed in 10 patients, while DLBCL was diagnosed in 17 patients. The median age of patients with ENKL was significantly lower than that of patients with DLBCL. All patients with ENKL had a unilateral lesion in the nasal cavity, with most located at the inferior turbinate. They also experienced nasal symptoms with significantly higher incidence of nasal obstruction and tendency of bleeding. Conclusion: ENKL was often unilateral and caused nasal obstruction, unlike DLBCL. Those who are younger in age and have sinonasal tumour with unilateral nasal obstruction and bleeding should be considered for early and repeated biopsies at multiple sites, with ENKL taken into consideration.
- Open Access
Delayed SARS-CoV-2 Spread and Olfactory Cell Lineage Impairment in Close-Contact Infection Syrian Hamster Models
Objectives Close contact with patients with COVID-19 is speculated to be the most common cause of viral transmission, but the pathogenesis of COVID-19 by close contact remains to be elucidated. In addition, despite olfactory impairment being a unique complication of COVID-19, the impact of SARS-CoV-2 on the olfactory cell lineage has not been fully validated. This study aimed to elucidate close-contact viral transmission to the nose and lungs and to investigate the temporal damage in the olfactory receptor neuron (ORN) lineage caused by SARS-CoV-2. Methods Syrian hamsters were orally administered SARS-CoV-2 as direct-infection models. On day 7 after inoculation, infected and uninfected hamsters were housed in the same cage for 30 minutes. These uninfected hamsters were subsequently assigned to a close-contact group. First, viral presence in the nose and lungs was verified in the infection and close-contact groups at several time points. Next, the impacts on the olfactory epithelium, including olfactory progenitors, immature ORNs, and mature ORNs, were examined histologically. Then, the viral transmission status and chronological changes in tissue damage were compared between the direct-infection and close-contact groups. Results In the close-contact group, viral presence could not be detected in both the nose and lungs on day 3, and the virus was identified in both tissues on day 7. In the direct-infection group, the viral load was highest in the nose and lungs on day 3, decreased on day 7, and was no longer detectable on day 14. Histologically, in the direct-infection group, mature ORNs were most depleted on day 3 (p < 0.001) and showed a recovery trend on day 14, with similar trends for olfactory progenitors and immature ORNs. In the close-contact group, there was no obvious tissue damage on day 3, but on day 7, the number of all ORN lineage cells significantly decreased (p < 0.001). Conclusion SARS-CoV-2 was transmitted even after brief contact and subsequent olfactory epithelium and lung damage occurred more than 3 days after the trigger of infection. The present study also indicated that SARS-CoV-2 damages all ORN lineage cells, but this damage can begin to recover approximately 14 days post infection.
Open AccessDelayed SARS-CoV-2 Spread and Olfactory Cell Lineage Impairment in Close-Contact Infection Syrian Hamster Models
Objectives Close contact with patients with COVID-19 is speculated to be the most common cause of viral transmission, but the pathogenesis of COVID-19 by close contact remains to be elucidated. In addition, despite olfactory impairment being a unique complication of COVID-19, the impact of SARS-CoV-2 on the olfactory cell lineage has not been fully validated. This study aimed to elucidate close-contact viral transmission to the nose and lungs and to investigate the temporal damage in the olfactory receptor neuron (ORN) lineage caused by SARS-CoV-2. Methods Syrian hamsters were orally administered SARS-CoV-2 as direct-infection models. On day 7 after inoculation, infected and uninfected hamsters were housed in the same cage for 30 minutes. These uninfected hamsters were subsequently assigned to a close-contact group. First, viral presence in the nose and lungs was verified in the infection and close-contact groups at several time points. Next, the impacts on the olfactory epithelium, including olfactory progenitors, immature ORNs, and mature ORNs, were examined histologically. Then, the viral transmission status and chronological changes in tissue damage were compared between the direct-infection and close-contact groups. Results In the close-contact group, viral presence could not be detected in both the nose and lungs on day 3, and the virus was identified in both tissues on day 7. In the direct-infection group, the viral load was highest in the nose and lungs on day 3, decreased on day 7, and was no longer detectable on day 14. Histologically, in the direct-infection group, mature ORNs were most depleted on day 3 (p < 0.001) and showed a recovery trend on day 14, with similar trends for olfactory progenitors and immature ORNs. In the close-contact group, there was no obvious tissue damage on day 3, but on day 7, the number of all ORN lineage cells significantly decreased (p < 0.001). Conclusion SARS-CoV-2 was transmitted even after brief contact and subsequent olfactory epithelium and lung damage occurred more than 3 days after the trigger of infection. The present study also indicated that SARS-CoV-2 damages all ORN lineage cells, but this damage can begin to recover approximately 14 days post infection.
- Open Access
- 1 December 2021
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 379 (3) , 400-408
Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
Acromegaly is a chronic systemic disease characterized by facial and peripheral changes caused by soft tissue overgrowth, together with multiple complications. Despite available surgical and medical therapies, suitable treatments for acromegaly are still lacking. Efficient drug development requires an understanding of the exposure-response (E-R) relationship based on non-clinical and early clinical studies. We aimed to establish a platform to facilitate the development of novel drugs to treat acromegaly. We evaluated the E-R relationship of the growth hormone (GH)-inhibitory effect of the somatostatin analogue, octreotide, under growth hormone-releasing hormone (GHRH) + arginine stimulation in healthy participants and compared the results with historical data for patients with acromegaly. This randomized five-way crossover study included two placebo and three active-treatment periods with different doses of octreotide acetate. GH secretion in the two placebo periods was comparable, confirming the reproducibility of the response with no carryover effect. GH secretion was inhibited by low-, medium-, and high-dose octreotide acetate, in a dose-dependent manner. We also examined the E-R relationship in monkeys as a preclinical drug evaluation study and in rats as a more convenient and simple system for screening candidate drugs. The E-R relationships and EC50 values were similar among animals, healthy paticipants and patients with acromegaly, which suggests that GH stimulation studies in early research and development stages allowed simulation of the drug responses in patients with acromegaly. Significance Statement We demonstrated similar exposure–response relationships in terms of the growth hormone-inhibitory effect of octreotide following growth hormone-releasing hormone stimulation among healthy participants, monkeys, and rats. The research methods and analyses utilized in this study will be useful for simulating the dosages and therapeutic effects of drugs for acromegaly, and will facilitate the research and development of novel therapeutic agents with similar modes of action.
- 1 December 2021
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 379 (3) , 400-408
Open AccessNovel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone–Inhibitory Effect of Octreotide after Growth Hormone–Releasing Hormone Stimulation
Acromegaly is a chronic systemic disease characterized by facial and peripheral changes caused by soft tissue overgrowth, together with multiple complications. Despite available surgical and medical therapies, suitable treatments for acromegaly are still lacking. Efficient drug development requires an understanding of the exposure-response (E-R) relationship based on non-clinical and early clinical studies. We aimed to establish a platform to facilitate the development of novel drugs to treat acromegaly. We evaluated the E-R relationship of the growth hormone (GH)-inhibitory effect of the somatostatin analogue, octreotide, under growth hormone-releasing hormone (GHRH) + arginine stimulation in healthy participants and compared the results with historical data for patients with acromegaly. This randomized five-way crossover study included two placebo and three active-treatment periods with different doses of octreotide acetate. GH secretion in the two placebo periods was comparable, confirming the reproducibility of the response with no carryover effect. GH secretion was inhibited by low-, medium-, and high-dose octreotide acetate, in a dose-dependent manner. We also examined the E-R relationship in monkeys as a preclinical drug evaluation study and in rats as a more convenient and simple system for screening candidate drugs. The E-R relationships and EC50 values were similar among animals, healthy paticipants and patients with acromegaly, which suggests that GH stimulation studies in early research and development stages allowed simulation of the drug responses in patients with acromegaly. Significance Statement We demonstrated similar exposure–response relationships in terms of the growth hormone-inhibitory effect of octreotide following growth hormone-releasing hormone stimulation among healthy participants, monkeys, and rats. The research methods and analyses utilized in this study will be useful for simulating the dosages and therapeutic effects of drugs for acromegaly, and will facilitate the research and development of novel therapeutic agents with similar modes of action.
- Open Access
- 18 December 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (12) , 10745-10753
Prognostic significance of combined radiologic imaging modalities for prognosis of clinical IA adenocarcinomas
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Hiroaki Kuroda1, Shnsuke Mori2, Hirotaka Tanaka3, Tatsuya Yoshida4, Tetsuya Mizuno1, Noriaki Sakakura1, Yasushi Yatabe2, Hiroshi Iwata3 and Yukinori Sakao1 1Department of Thoracic Surgery, Aichi Cancer Center Hospital, Aichi, Japan 2Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Aichi, Japan 3East Nagoya Radiological Diagnosis Foundation, Aichi, Japan 4Department of Thoracic Oncology, Aichi Cancer Center Hospital, Aichi, Japan Correspondence to: Hiroaki Kuroda, email: h-kuroda@aichi-cc.jp. Keywords: three-dimensional; mediastinal size; invasive size; positron emission tomography; adenocarcinoma Received: September 16, 2016 Accepted: November 12, 2017 Published: December 18, 2017 ABSTRACT Background: We previously proposed measuring tumor size using mediastinal window setting on high-resolution computed tomography (CT) as a simple and useful modality for preoperative prognostication of small adenocarcinoma. Hence, the importance of tumor volume and positron emission tomography (PET) for preoperative prognostication of clinical stage IA (cIA) adenocarcinoma was studied. Materials and Methods: We retrospectively evaluated total 324 patients who underwent pulmonary resection of cIA adenocarcinoma between July 2008 and August 2015. Reconstructed three-dimensional (3D) images from 1–1.5 mm-sliced CT were evaluated for whole tumor volume including ground grass opacity, consolidation volume on lung window setting, and mediastinal window volume (MWV). The values examined by PET were total lesion glycolysis (TLG), and maximum standardized uptake (SUV max) and mean. Pathologic status was evaluated according to tumor maximum size, invasive size (IS), lymphatic and vascular vessels, pleural invasion (ly/v/pl), and TNM staging. Results: According to ly/v/pl invasion and lymph node positivity, no variables were superior to IS. We used Mean/MWV (SUV mean x MWV) to evaluate tumor quality and quantity in the role of surrogate TLG. Mean/MWV were superior to IS. Additionally, Mean/MV was associated with lymph node metastases. Among the various histologic subtypes, solid-predominant had the highest expression of Mean/MV. The higher Mean/MV significantly contributed to unfavorable disease-free survival in cIA adenocarcinomas, but not to overall survival. Conclusions: The mean/MWV value determination on 3D-reconstructed CT images was a simple and useful preoperative modality for predicting invasive facet in cIA adenocarcinoma. However, higher values didn’t significantly affect overall survival.
- 18 December 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (12) , 10745-10753
Open AccessPrognostic significance of combined radiologic imaging modalities for prognosis of clinical IA adenocarcinomas
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Hiroaki Kuroda1, Shnsuke Mori2, Hirotaka Tanaka3, Tatsuya Yoshida4, Tetsuya Mizuno1, Noriaki Sakakura1, Yasushi Yatabe2, Hiroshi Iwata3 and Yukinori Sakao1 1Department of Thoracic Surgery, Aichi Cancer Center Hospital, Aichi, Japan 2Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Aichi, Japan 3East Nagoya Radiological Diagnosis Foundation, Aichi, Japan 4Department of Thoracic Oncology, Aichi Cancer Center Hospital, Aichi, Japan Correspondence to: Hiroaki Kuroda, email: h-kuroda@aichi-cc.jp. Keywords: three-dimensional; mediastinal size; invasive size; positron emission tomography; adenocarcinoma Received: September 16, 2016 Accepted: November 12, 2017 Published: December 18, 2017 ABSTRACT Background: We previously proposed measuring tumor size using mediastinal window setting on high-resolution computed tomography (CT) as a simple and useful modality for preoperative prognostication of small adenocarcinoma. Hence, the importance of tumor volume and positron emission tomography (PET) for preoperative prognostication of clinical stage IA (cIA) adenocarcinoma was studied. Materials and Methods: We retrospectively evaluated total 324 patients who underwent pulmonary resection of cIA adenocarcinoma between July 2008 and August 2015. Reconstructed three-dimensional (3D) images from 1–1.5 mm-sliced CT were evaluated for whole tumor volume including ground grass opacity, consolidation volume on lung window setting, and mediastinal window volume (MWV). The values examined by PET were total lesion glycolysis (TLG), and maximum standardized uptake (SUV max) and mean. Pathologic status was evaluated according to tumor maximum size, invasive size (IS), lymphatic and vascular vessels, pleural invasion (ly/v/pl), and TNM staging. Results: According to ly/v/pl invasion and lymph node positivity, no variables were superior to IS. We used Mean/MWV (SUV mean x MWV) to evaluate tumor quality and quantity in the role of surrogate TLG. Mean/MWV were superior to IS. Additionally, Mean/MV was associated with lymph node metastases. Among the various histologic subtypes, solid-predominant had the highest expression of Mean/MV. The higher Mean/MV significantly contributed to unfavorable disease-free survival in cIA adenocarcinomas, but not to overall survival. Conclusions: The mean/MWV value determination on 3D-reconstructed CT images was a simple and useful preoperative modality for predicting invasive facet in cIA adenocarcinoma. However, higher values didn’t significantly affect overall survival.
- Open Access
- 1 January 2015
- Published by Kaifukuki Rehabilitation Ward Association in Japanese Journal of Comprehensive Rehabilitation Science
- Vol. 6, 21-26
Comparison between gait-assisting robot (WPAL) and bilateral knee-ankle-foot orthoses with a medial single hip joint in gait reconstruction for patients with paraplegia
Hirano S, Saitoh E, Tanabe S, Katoh M, Shimizu Y, Yatsuya K, Tanaka H, Kagaya H, Ishihara K, Uno A. Comparison between gait-assisting robot (WPAL) and bilateral knee-ankle-foot orthoses with a medial single hip joint in gait reconstruction for patients with paraplegia. Jpn J Compr Rehabil Sci 2015; 6: 21-26. Objective: To evaluate the utility of a gait-assisting robot, Wearable Power-Assist Locomotor (WPAL), in gait reconstruction for patients with paraplegia. Subjects and Methods: The subjects were 12 patients with paraplegia who were able to walk with minimum assistance, under supervision, or without any assistance and supervision using a bilateral knee-ankle-foot orthoses with a medial single hip joint or WPAL. The duration and distance of walking were measured and the required level of assistance was evaluated with the Functional Ambulation Category (FAC) scale as the subjects walked at a comfortable speed with the orthoses or WPAL. Results: The duration and distance of walking with the WPAL were significantly longer in 8 and 11 subjects, respectively, compared with use of the orthoses. FAC scores were 2, 3 or 4 with orthoses and 4 using the WPAL, indicating less assistance was needed with the WPAL. Conclusion: The WPAL enabled patients with paraplegia to walk for a longer time and longer distance with less assistance.
- 1 January 2015
- Published by Kaifukuki Rehabilitation Ward Association in Japanese Journal of Comprehensive Rehabilitation Science
- Vol. 6, 21-26
Open AccessComparison between gait-assisting robot (WPAL) and bilateral knee-ankle-foot orthoses with a medial single hip joint in gait reconstruction for patients with paraplegia
Hirano S, Saitoh E, Tanabe S, Katoh M, Shimizu Y, Yatsuya K, Tanaka H, Kagaya H, Ishihara K, Uno A. Comparison between gait-assisting robot (WPAL) and bilateral knee-ankle-foot orthoses with a medial single hip joint in gait reconstruction for patients with paraplegia. Jpn J Compr Rehabil Sci 2015; 6: 21-26. Objective: To evaluate the utility of a gait-assisting robot, Wearable Power-Assist Locomotor (WPAL), in gait reconstruction for patients with paraplegia. Subjects and Methods: The subjects were 12 patients with paraplegia who were able to walk with minimum assistance, under supervision, or without any assistance and supervision using a bilateral knee-ankle-foot orthoses with a medial single hip joint or WPAL. The duration and distance of walking were measured and the required level of assistance was evaluated with the Functional Ambulation Category (FAC) scale as the subjects walked at a comfortable speed with the orthoses or WPAL. Results: The duration and distance of walking with the WPAL were significantly longer in 8 and 11 subjects, respectively, compared with use of the orthoses. FAC scores were 2, 3 or 4 with orthoses and 4 using the WPAL, indicating less assistance was needed with the WPAL. Conclusion: The WPAL enabled patients with paraplegia to walk for a longer time and longer distance with less assistance.